
Trump Tariffs on Pharmaceuticals Risk Causing Higher Costs, Drug Shortages
In recent weeks, the Trump administration has signaled that it views foreign pharmaceutical manufacturing as a national security concern, prompting the Department of Commerce to launch a Section 232 investigation into pharmaceutical imports, as outlined in …